Content provided by Deborah Roberts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Deborah Roberts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
1.5 - Dr Reid Robison: Undoing Rigid Thinking
MP3•Episode home
Manage episode 287770142 series 2896878
Content provided by Deborah Roberts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Deborah Roberts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Reid Robison, MD MBA, is a psychedelic psychiatrist & researcher.
Reid has led over 100 clinical trials in neuropsychiatry. He completed his undergraduate in Neuroscience at Brigham Young University and went on to medical school at the University of Utah where he earned both his MD and MBA. Of course, he didn’t stop there, after residency training in Psychiatry, Dr Robison completed fellowship training in Neurodevelopmental Genetics, followed by a postdoc in Bioinformatics.
As an early adopter and researcher of Ketamine in psychiatry, Reid obtained his first grant to study ketamine in 2011. He also led the Utah site for the pivotal ketamine study for TRMDD by Janssen, leading up to the company’s recent FDA-approval of Spravato. To date, Reid has guided thousands of ketamine therapy journeys and hundreds of Spravato dosing sessions.
Reid has built a number of therapeutic-driven companies including Tute Genomics, a venture-backed personalized medicine startup that was acquired in 2016, Cedar Psychiatry, which he co founded and serves as a Medical Director of Center for Change, a top Eating Disorder program. He is also a founding board member at the Utah-based non-profit organisation Psychedelic Institute. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad, and is the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders.
In this episode:
- Mental health crisis
- Epigenetics and genetics in mental health conditions
- Resetting and opening up new neural pathways
- Neuroscience of ketamine
- Pharmacogenetics
Links:
Support the podcast:
Support the mission:
Donate to Mind Medicine Australia
Support this show http://supporter.acast.com/mind-medicine-australia.
Become a member at https://plus.acast.com/s/mind-medicine-australia.
Hosted on Acast. See acast.com/privacy for more information.
50 episodes
MP3•Episode home
Manage episode 287770142 series 2896878
Content provided by Deborah Roberts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Deborah Roberts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Reid Robison, MD MBA, is a psychedelic psychiatrist & researcher.
Reid has led over 100 clinical trials in neuropsychiatry. He completed his undergraduate in Neuroscience at Brigham Young University and went on to medical school at the University of Utah where he earned both his MD and MBA. Of course, he didn’t stop there, after residency training in Psychiatry, Dr Robison completed fellowship training in Neurodevelopmental Genetics, followed by a postdoc in Bioinformatics.
As an early adopter and researcher of Ketamine in psychiatry, Reid obtained his first grant to study ketamine in 2011. He also led the Utah site for the pivotal ketamine study for TRMDD by Janssen, leading up to the company’s recent FDA-approval of Spravato. To date, Reid has guided thousands of ketamine therapy journeys and hundreds of Spravato dosing sessions.
Reid has built a number of therapeutic-driven companies including Tute Genomics, a venture-backed personalized medicine startup that was acquired in 2016, Cedar Psychiatry, which he co founded and serves as a Medical Director of Center for Change, a top Eating Disorder program. He is also a founding board member at the Utah-based non-profit organisation Psychedelic Institute. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad, and is the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders.
In this episode:
- Mental health crisis
- Epigenetics and genetics in mental health conditions
- Resetting and opening up new neural pathways
- Neuroscience of ketamine
- Pharmacogenetics
Links:
Support the podcast:
Support the mission:
Donate to Mind Medicine Australia
Support this show http://supporter.acast.com/mind-medicine-australia.
Become a member at https://plus.acast.com/s/mind-medicine-australia.
Hosted on Acast. See acast.com/privacy for more information.
50 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.